Jennison Associates LLC Has $45.10 Million Stock Holdings in Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Jennison Associates LLC trimmed its position in Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 16.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,329,095 shares of the biopharmaceutical company’s stock after selling 252,995 shares during the quarter. Jennison […]

Leave a Reply

Your email address will not be published.

Previous post Ex-Soviet state to nationalize branch of world’s second-largest steelmaker
Next post Halliburton (NYSE:HAL) Shares Sold by Jennison Associates LLC